Tapewire

Nasdaq · USD

PBLS

Parabilis Medicines, Inc.

Export transactions ↓
Tapewire entity
3933
SEC CIK
0001657677
Parsed reports
34

Last 12 months

Inside the activity.

14 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202680
Jul 202660
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 09, 2026 Filed Jun 11, 2026 20:53 UTC GrantStock Option (Right to Buy) · Derivative 20,215 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0001193125-26-267806 · ownership.xml · derivative · entry 1

Borisy Alexis · CIK 0001319446 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,215

Underlying: Common Stock · 20,215 shares

Expires 2036-06-08

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) June 9, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 22:36 UTC GrantStock Option (Right to Buy) · Derivative 20,215 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0001231919-26-000623 · form4-06112026_100601.xml · derivative · entry 1

RA CAPITAL MANAGEMENT, L.P. · CIK 0001346824 · Director

RA Capital Healthcare Fund LP · CIK 0001315082 · Director

RA Capital Nexus Fund III, L.P. · CIK 0001883840 · Director

Kolchinsky Peter · CIK 0001384859 · Director

Shah Rajeev M. · CIK 0001619841 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 20,215

Underlying: Common Stock · 20,215 shares

Expires 2036-06-08

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) June 9, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to Dr. Simson's continued service on such vesting date.

F2 · ownership.nature: RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund III, L.P. (the "Nexus Fund III"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund III, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.

F3 · ownership.nature: Under Dr. Simson's arrangement with the Adviser, Dr. Simson holds the option for the benefit of the Fund and the Nexus Fund III. Dr. Simson is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option, which will offset advisory fees owed by the Fund and the Nexus Fund III to the Adviser. The Reporting Persons therefore disclaim beneficial ownership of the option and underlying common stock.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 20:52 UTC GrantStock Option (Right to Buy) · Derivative 20,215 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0001193125-26-267797 · ownership.xml · derivative · entry 1

Yeshwant Krishna · CIK 0001585001 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,215

Underlying: Common Stock · 20,215 shares

Expires 2036-06-08

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) June 9, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 20:48 UTC GrantStock Option (Right to Buy) · Derivative 20,215 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0001193125-26-267769 · ownership.xml · derivative · entry 1

FITZGERALD EDWARD M · CIK 0001242993 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,215

Underlying: Common Stock · 20,215 shares

Expires 2036-06-08

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) June 9, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 20:43 UTC GrantStock Option (Right to Buy) · Derivative 20,215 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0001193125-26-267747 · ownership.xml · derivative · entry 1

Klausner Richard · CIK 0001591178 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,215

Underlying: Common Stock · 20,215 shares

Expires 2036-06-08

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) June 9, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.